Mayer-Rokitansky-Küster-Hauser syndrome

Last revised by Bouhouche abdeldjalil on 26 Mar 2023

Mayer-Rokitansky-Küster-Hauser syndrome (MRKH), also known as Müllerian aplasia, is a congenital anomaly characterized by vaginal and uterine aplasia or agenesis 9. It is usually also associated with a spectrum of other genitourinary tract abnormalities. MRKH syndrome belongs to class I Mullerian duct anomalies.

Two different forms are described:

  • the typical form (type A) of this syndrome is characterized by congenital absence of the uterus and upper 2/3 vagina with normal ovaries and fallopian tubes
  • the atypical form (type B) of the syndrome includes associated abnormalities of the ovaries and fallopian tubes and renal anomalies

It has a reported incidence of ~1:4000-5000 live female births.

The typical presentation is that of primary amenorrhea, with normal hormonal levels guaranteed by fully functional gonads. At times cyclic pelvic pain may be present in the post-pubertal period due to an accumulation of hemorrhagic material within uterine buds with a functioning endometrium.

The anomaly is thought to arise during embryogenesis, with arrested development of the paramesonephric ducts at ~7 weeks after fertilisation.

MRKH syndrome is generally characterized by normal external genitalia and absence or reduced development of the uterus and upper two-thirds of the vagina.

The fallopian tubes, uterus, cervix and upper ¾ of vagina develop from the Müllerian ducts from the 8th-12th gestational weeks. A developmental defect occurring at this stage leads to agenesis of Müllerian structures. The development of kidneys, ureter, and bladder occurs concomitantly at around the 6th-12th weeks of gestation. The presence of residual components such as a blind vaginal pouch and a rudimentary uterus (non-functioning myometrial tissue) are noted in a significant proportion of patients.

The syndrome is often associated with alterations in the urinary or skeletal system which include:

Although hysterosalpingography has a well-established use in characterizing uterine Mullerian duct anomalies, it has no place in MRKH syndrome given the hypoplasia/agenesis of the uterus and 2/3 of vagina.

Usually there is absence of the uterus and normal ovaries. Also, ultrasound may demonstrate any associated renal tract anomaly. 

This is the imaging modality of choice after initial assessment with ultrasound, allowing characterization of the uterine buds and presence of functioning endometrium within them. 

It is named after the German physician August Franz Josef Karl Mayer (1787-1865), Austrian pathologist Karl Freiherr von Rokitansky (1804-1878), German gynecologist Hermann Küster (1879-?) and the Swiss physician Georges André​ Hauser (1921-?) 7,8.

ADVERTISEMENT: Supporters see fewer/no ads

Cases and figures

  • Case 1: sagittal T2
    Drag here to reorder.
  • Case 2: axial T2
    Drag here to reorder.
  • Case 3: MRKH and renal agenesis
    Drag here to reorder.
  • Case 4
    Drag here to reorder.
  • Case 5: with rudimentary uterine horns
    Drag here to reorder.
  • Case 6: with crossed fused renal ectopia (CT)
    Drag here to reorder.
  • Case 7
    Drag here to reorder.
  • Case 8
    Drag here to reorder.
  • Case 9
    Drag here to reorder.
  • Case 10
    Drag here to reorder.
  • Case 11
    Drag here to reorder.
  • Case 12
    Drag here to reorder.
  • Case 13: with bilateral pelvic kidneys
    Drag here to reorder.
  • Case 14: with ovarian torsion
    Drag here to reorder.
  • Case 15: with persistent descending mesocolon
    Drag here to reorder.
  • Case 16: with rudimentary uterine horns
    Drag here to reorder.
  • Case 17: with gonadal dysgenesis
    Drag here to reorder.
  • Updating… Please wait.

     Unable to process the form. Check for errors and try again.

     Thank you for updating your details.